TrialRenal failure2025

The efficacy and safety of rituximab monotherapy in the new onset pediatric idiopathic nephrotic syndrome: a randomized controlled clinical trial.

Ai-Qin Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.